BASEM GOUELI
Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology WILLIAMSVILLE, NY NPI 1699064089
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology NY Genentech USA, Inc. All categories
General Payments — all program years on this page
$56,639.37
- Category: General Payments
- Program years: PY2018–2024
- Record count: 84
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $3,651.83 across 44 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,660.00 | 1 |
| Food and Beverage | $991.83 | 43 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Genentech USA, Inc. | $2,660.00 | 1 |
| Janssen Biotech, Inc. | $170.94 | 8 |
| Merck Sharp & Dohme Corporation | $100.21 | 4 |
| Daiichi Sankyo Inc. | $89.92 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $78.57 | 4 |
| Grifols USA, LLC | $65.36 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $57.92 | 2 |
| E.R. Squibb & Sons, L.L.C. | $56.16 | 2 |
| Acerta Pharma LLC | $46.55 | 2 |
| ARRAY BIOPHARMA INC | $46.27 | 2 |
| PFIZER INC. | $40.45 | 2 |
| Tempus AI, Inc | $37.00 | 2 |
| Deciphera Pharmaceuticals Inc. | $32.82 | 1 |
| GENZYME CORPORATION | $25.82 | 1 |
| Myriad Genetic Laboratories, Inc. | $22.11 | 1 |
| BeiGene USA, Inc. | $22.03 | 1 |
| GlaxoSmithKline, LLC. | $21.08 | 1 |
| Astellas Pharma US Inc | $20.56 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $20.01 | 1 |
| ABBVIE INC. | $19.21 | 1 |
| Alnylam Pharmaceuticals Inc. | $18.84 | 1 |
By program year
Records — PY2024 (44)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.